e2022
Small moleculeexperimental
Clinical trial activity
5 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2010 (NCT01253434)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- e2022
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02225288 | Phase 1 | Sep 1, 2014 | Eisai |
| NCT01843556 | Phase 1 | Dec 1, 2012 | Eisai |
| NCT02042729 | Phase 1 | Aug 1, 2012 | Eisai |
| NCT01450839 | Phase 1 | Sep 1, 2011 | Eisai |
| NCT01253434 | Phase 1 | Nov 1, 2010 | Eisai |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Eisai | For profit | 5 | 5 | 1 | 2010 |
1 organizations
Page 1 / 1